3/15
08:39 am
asnd
Rating for ASND
Low
Report
Rating for ASND
3/15
08:39 am
asnd
Rating for ASND
Low
Report
Rating for ASND
2/8
11:06 am
asnd
Rating for ASND
Low
Report
Rating for ASND
2/8
11:06 am
asnd
Rating for ASND
Low
Report
Rating for ASND
2/8
08:25 am
asnd
Rating for ASND
Low
Report
Rating for ASND
2/8
08:25 am
asnd
Rating for ASND
Low
Report
Rating for ASND
2/6
09:47 am
asnd
Rating for ASND
Low
Report
Rating for ASND
1/8
12:25 pm
asnd
Ascendis Pharma A/S (NASDAQ: ASND) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $207.00 price target on the stock, up previously from $202.00.
Medium
Report
Ascendis Pharma A/S (NASDAQ: ASND) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $207.00 price target on the stock, up previously from $202.00.
1/8
12:25 pm
asnd
Ascendis Pharma A/S (NASDAQ: ASND) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $207.00 price target on the stock, up previously from $202.00.
Medium
Report
Ascendis Pharma A/S (NASDAQ: ASND) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $207.00 price target on the stock, up previously from $202.00.
12/20
10:55 am
asnd
Ascendis Pharma A/S (NASDAQ: ASND) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $152.00 price target on the stock.
Low
Report
Ascendis Pharma A/S (NASDAQ: ASND) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $152.00 price target on the stock.
12/20
10:21 am
asnd
Rating for ASND
Low
Report
Rating for ASND
12/20
08:56 am
asnd
Rating for ASND
Low
Report
Rating for ASND
12/20
08:56 am
asnd
Rating for ASND
Low
Report
Rating for ASND
12/20
06:36 am
asnd
Rating for ASND
Low
Report
Rating for ASND
12/20
06:36 am
asnd
Rating for ASND
Low
Report
Rating for ASND